0001628280-23-041113.txt : 20231208 0001628280-23-041113.hdr.sgml : 20231208 20231208104602 ACCESSION NUMBER: 0001628280-23-041113 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20231207 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20231208 DATE AS OF CHANGE: 20231208 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Aquestive Therapeutics, Inc. CENTRAL INDEX KEY: 0001398733 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 208623253 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-38599 FILM NUMBER: 231474317 BUSINESS ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 BUSINESS PHONE: 908-941-1900 MAIL ADDRESS: STREET 1: 30 TECHNOLOGY DRIVE CITY: WARREN STATE: NJ ZIP: 07059 FORMER COMPANY: FORMER CONFORMED NAME: MonoSol Rx, Inc. DATE OF NAME CHANGE: 20070507 8-K 1 aqst-20231207.htm 8-K aqst-20231207
0001398733false00013987332023-12-072023-12-07

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549

FORM 8-K

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): December 7, 2023
Aquestive Therapeutics, Inc.
(Exact name of Registrant as specified in its charter)
Delaware001-3859982-3827296
(State or Other Jurisdiction of Incorporation or Organization)(Commission File Number)(I.R.S. Employer Identification No.)

30 Technology Drive
Warren, NJ 07059
(908) 941-1900
(Address, Including Zip Code, and Telephone Number, Including Area Code, of Registrant’s Principal Executive Offices)

Not Applicable
(Former name or former address, if changed since last report)
________________________________________________________________________________________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each classTrading Symbol(s)Name of each exchange on which
registered
Common Stock, par value $0.001 per shareAQSTNasdaq Global Market

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company ☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐


Item 7.01Regulation FD Disclosure
On December 7, 2023, Mark Schobel, Chief Innovation & Technology Officer of Aquestive Therapeutics, Inc., a Delaware corporation (the "Company"), adopted a written sales plan in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended (the "Plan") for trading 175,000 shares.

Transactions made under the Plan will be reported to the Securities and Exchange Commission in accordance with applicable securities laws, rules, and regulations. Except as may be so required, the Company does not undertake any obligation to update or report any modification, termination, or other activity under the Plan or any other plan that may be adopted by other officers or directors of the Company.





SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: December 7, 2023
Aquestive Therapeutics, Inc.
By:/s/ A. Ernest Toth, Jr
Name: A. Ernest Toth, Jr.
Title: Chief Financial Officer
(Principal Financial Officer)


    

 EX-101.SCH 2 aqst-20231207.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 aqst-20231207_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Security Exchange Name Security Exchange Name Title of 12(b) Security Title of 12(b) Security Written Communications Written Communications Local Phone Number Local Phone Number Trading Symbol Trading Symbol Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Document Period End Date Document Period End Date Cover [Abstract] Entity Emerging Growth Company Entity Emerging Growth Company Pre-commencement Tender Offer Pre-commencement Tender Offer Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Postal Zip Code Entity Address, Postal Zip Code Document Type Document Type Amendment Flag Amendment Flag Entity Central Index Key Entity Central Index Key Entity Ex Transition Period Entity Ex Transition Period Entity File Number Entity File Number Entity Address, City or Town Entity Address, City or Town Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address, Address Line One Entity Registrant Name Entity Registrant Name EX-101.PRE 4 aqst-20231207_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.23.3
Cover
Dec. 07, 2023
Cover [Abstract]  
Document Type 8-K
Document Period End Date Dec. 07, 2023
Entity Registrant Name Aquestive Therapeutics, Inc.
Entity Incorporation, State or Country Code DE
Entity File Number 001-38599
Entity Tax Identification Number 82-3827296
Entity Address, Address Line One 30 Technology Drive
Entity Address, City or Town Warren
Entity Address, State or Province NJ
Entity Address, Postal Zip Code 07059
City Area Code (908)
Local Phone Number 941-1900
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol AQST
Security Exchange Name NASDAQ
Entity Emerging Growth Company true
Entity Ex Transition Period false
Entity Central Index Key 0001398733
Amendment Flag false
XML 6 aqst-20231207_htm.xml IDEA: XBRL DOCUMENT 0001398733 2023-12-07 2023-12-07 0001398733 false 8-K 2023-12-07 Aquestive Therapeutics, Inc. DE 001-38599 82-3827296 30 Technology Drive Warren NJ 07059 (908) 941-1900 false false false false Common Stock, par value $0.001 per share AQST NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.3 html 1 23 1 false 0 0 false 0 false false R1.htm 0000001 - Document - Cover Sheet http://aquestive.com/role/Cover Cover Cover 1 false false All Reports Book All Reports aqst-20231207.htm aqst-20231207.xsd aqst-20231207_lab.xml aqst-20231207_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 12 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "aqst-20231207.htm": { "nsprefix": "aqst", "nsuri": "http://aquestive.com/20231207", "dts": { "inline": { "local": [ "aqst-20231207.htm" ] }, "schema": { "local": [ "aqst-20231207.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "aqst-20231207_lab.xml" ] }, "presentationLink": { "local": [ "aqst-20231207_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://aquestive.com/role/Cover", "longName": "0000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "aqst-20231207.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "c-1", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "div", "body", "html" ], "reportCount": 1, "baseRef": "aqst-20231207.htm", "first": true, "unique": true } } }, "tag": { "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Tender Offer", "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, City or Town", "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Cover [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Address Line One", "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Local Phone Number", "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, Postal Zip Code", "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Ex Transition Period", "label": "Entity Ex Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r7" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Emerging Growth Company", "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Trading Symbol", "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Registrant Name", "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Title of 12(b) Security", "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Address, State or Province", "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity File Number", "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Type", "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Document Period End Date", "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "City Area Code", "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Tax Identification Number", "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Amendment Flag", "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Soliciting Material", "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Incorporation, State or Country Code", "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Pre-commencement Issuer Tender Offer", "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Security Exchange Name", "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Written Communications", "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://aquestive.com/role/Cover" ], "lang": { "en-us": { "role": { "terseLabel": "Entity Central Index Key", "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 13 0001628280-23-041113-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001628280-23-041113-xbrl.zip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